Project Grant K23NS149280
Award Date 9/1/26
Completion Date 8/31/31
Dollars Obligated $228K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Cincinnati, OH 45229, USA
Similar Awards
- The National Institute of Child Health and Human Development awarded Washington University $667,506 on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to develop a caregiver-reported dystonia impact scale for children with cerebral palsy. The project addresses underdiagnosis of dystonia in cerebral palsy, a condition affecting 1 in 500 people in the United States. Dystonia commonly causes motor functional limitations in childhood but is...
- The National Institute of Neurological Disorders and Stroke awarded Virginia Commonwealth University $173,335 on August 15, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to develop and validate clinical outcome assessments for congenital myotonic dystrophy in children. The project addresses gaps in measuring motor function change in congenital myotonic dystrophy (CDM), a severe inherited disorder characterized by progressive...
- The National Institute of Neurological Disorders and Stroke awarded The Children's Hospital of Philadelphia $221,400 on May 15, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to support a K08 mentored research career development award focused on striatal interneuron dysfunction in autism spectrum disorder and Dravet syndrome. The award funds a training program designed to position the principal investigator, an instructor in the...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded Cincinnati Children's Hospital Medical Center a $900,000 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) on September 18, 2025, with an ultimate completion date of August 31, 2030. This mechanistic and translational medicine research initiative addresses critical knowledge gaps in Fragile X Syndrome (FXS) by establishing...
- The National Institute of Neurological Disorders and Stroke awarded Cincinnati Children's Hospital Medical Center $1.614 million on September 11, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to conduct basic research on epileptogenesis mechanisms in mtoropathies and develop AAV-mediated gene therapy approaches for intractable epilepsy caused by mTOR pathway mutations. The research leverages newly developed mouse models of...
- The National Institute of Neurological Disorders and Stroke awarded the Research Institute at Nationwide Children's Hospital $692,802 on July 1, 2026, to establish a training program in basic and translational gene therapy research under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The training program will prepare the next generation of clinicians and scientists to develop and deliver gene therapies, building on the Center for Gene...
- The National Institute of Child Health and Human Development awarded The Spaulding Rehabilitation Hospital Corporation $170,640 on July 15, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to support a K23 career development award investigating childhood stroke predictors of motor recovery. The award funds a physician-scientist's career development and research program centered on neurorecovery mechanisms in pediatric acquired brain injury, with...
- FEDERAL GRANT AWARD SUMMARY Cincinnati Children's Hospital Medical Center received a $803,958 Project Grant award (announced July 23, 2025) from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award supports research and development of an innovative nanocarrier-based therapeutic delivery system designed to treat neuronopathic Gaucher disease (NGD), a severe...
- The National Institute of Neurological Disorders and Stroke awarded Cedars-Sinai Medical Center $190,321 on August 15, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate the neurophysiology of cognitive control and its development using single unit intracranial recordings in pediatric patients with epilepsy. The research examines how adaptive behavioral control develops during childhood and is instantiated by...
- The National Institute of Neurological Disorders and Stroke awarded Virginia Commonwealth University $194,907 on July 10, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to support a mentored career development project identifying genetic modifiers of disease severity in myotonic dystrophy type 1. Dr. Samuel Carrell, an Assistant Professor of Neurology at Virginia Commonwealth University, leads the research effort. The award...